Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
12/2010
12/08/2010CN101910173A Derivatives of 2-heteroaroyl-imidazol[1,2-a] pyridine, preparation thereof and therapeutic application thereof
12/08/2010CN101910172A Derivatives of n-heterocyclic-imidazo[1,2-a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof
12/08/2010CN101910171A Nonsteroidal compounds useful as modulators of glucocorticoid receptor AP-1 and/or NF-kappa B activity and use thereof
12/08/2010CN101910152A 4-pyrazolyl-N-arylpyrimidin-2-amines and 4-pyrazolyl-N-heteroarylpyrimidin-2-amines as janus kinase inhibitors
12/08/2010CN101910151A Bicyclic heterocycle derivatives and their use as modulators of the activity of GPR119
12/08/2010CN101910142A Modulators for amyloid beta
12/08/2010CN101910127A (aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor
12/08/2010CN101909659A Use of novel compound having affinity for amyloid, and process for production of the same
12/08/2010CN101909658A Use of novel compound having affinity for amyloid, and process for production of the same
12/08/2010CN101909657A Use of novel compound having affinity for amyloid, and process for production of the same
12/08/2010CN101906104A 2-(pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones
12/08/2010CN101906103A Improvement on synthesis method of tetrahydro-beta-carboline compound (II)
12/08/2010CN101906102A Beta-carboline alkaloid derivative, preparation method and application thereof
12/08/2010CN101906096A 3,4-dihydropyridine-2-ketone heterocyclic compound and application thereof
12/08/2010CN101481357B Preparation of quinoxaline derivatives
12/07/2010US7846956 Malononitrile compound as pesticides
12/07/2010US7846941 Compounds modulating c-kit and c-fms activity and uses therefor
12/07/2010US7846932 Methods for the use of pyrimidine derivatives which are antagonists of vitronectin receptor
12/07/2010US7846928 Interfere with Tie2 signalling; Tie (tyrosine kinase with immunoglobulin and epidermal growth factor homology domain) receptor tyrosine kinase; antitumor, antimetastasis agents; for example, 1-[4-(6-tert-Butyl-1H-pyrazolo[3,4-b]pyridin-4-yl)-phenyl]-3-(3-ethyl-phenyl)-urea
12/07/2010US7846923 such as N-ethyl-3-(9-ethyl-8-oxo-8,9-dihydro-3H-3,4,9-triaza-cyclopenta[a]naphthalen-7-yl)-5-methoxy-benzamide, used to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity
12/07/2010CA2436409C Kappa opioid receptor ligands
12/07/2010CA2434203C 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof
12/02/2010WO2010138644A1 Processes for the preparation of substituted tetrahydro beta-carbolines
12/02/2010WO2010138588A2 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
12/02/2010WO2010138576A1 Pyrimidine inhibitors of kinase activity
12/02/2010WO2010138575A1 Pyrimidine inhibitors of kinase activity
12/02/2010WO2010138490A1 Benzoxazepines as inhibitors of mtor and methods of their use and manufacture
12/02/2010WO2010138487A1 BENZOXAZEPINES AS INHIBITORS OF PI3K/m TOR AND METHODS OF THEIR USE AND MANUFACTURE
12/02/2010WO2010137738A1 Heterocyclic compounds for the treatment of stress-related conditions
12/02/2010WO2010137350A1 Agent for treatment or prevention of diseases associated with activity of neurotrophic factors
12/02/2010WO2010136895A1 Solid state forms of paliperidone salts and process for the preparation thereof
12/02/2010WO2010136817A1 Heterocyclic urea derivatives and methods of use thereof
12/02/2010WO2010136778A1 Dibenzothiophene derivatives as dna- pk inhibitors
12/02/2010WO2010136438A1 (dihydro) imidazoiso (5, 1-a) quinolines as fsh receptor agonists for the treatment of fertility disorders
12/02/2010WO2010136109A1 Materials for organic electroluminescent devices
12/02/2010WO2010136037A1 Novel calcium sensing receptor modulating compounds and pharmaceutical use thereof
12/02/2010WO2010135944A1 Salts of methyl (r)-7-[3-amino-4-(2,4,5-trifluoro-phenyl)-butyryl]-3-trifluoromethyl-5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine-1-carboxylate
12/02/2010WO2010111418A3 Process for the production of fused, tricyclic sulfonamides
12/02/2010WO2010035219A3 Pyrazolo pyridine derivatives as nadph oxidase inhibitors
12/02/2010WO2010003702A9 Synthesis of paliperidone
12/02/2010US20100305324 Pharmaceutical composition for preventing or treating osteoporosis or obesity comprising phenyltetrazole derivative
12/02/2010US20100305142 3-aminoimidazo 1,2-a pyridine derivatives having an sglt1- and sglt2-inhibiting action for the treatment of type 1 and type 2 diabetes
12/02/2010US20100305136 Quinolone analogs derivatized with sulfonic acid, sulfonate or sulfonamide
12/02/2010US20100305122 Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
12/02/2010US20100305114 Heterocyclic Aromatic Compounds Useful As Growth Hormone Secretagogues
12/02/2010US20100305108 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidine derivatives and their medical use
12/02/2010US20100305096 Bicyclic pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
12/02/2010US20100305091 PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES
12/02/2010US20100305089 Fused Bicycloheterocycle Substituted Azabicyclic Alkane Derivatives
12/02/2010US20100305070 Treatment or prophylaxis of proliferative conditions
12/02/2010US20100305052 Substituted 4-aryl-1,4-dihydro-1,6-naphthyridines and use thereof
12/02/2010CA2763631A1 Pyrimidine inhibitors of kinase activity
12/02/2010CA2763624A1 Pyrimidine inhibitors of kinase activity
12/02/2010CA2763485A1 Methods for treating cancer and non-neoplastic conditions
12/02/2010CA2763479A1 Processes for the preparation of substituted tetrahydro beta-carbolines
12/02/2010CA2763118A1 (dihydro) imidazoiso (5, 1-a)quinolines as fsh receptor agonists for the treatment of fertility disorders
12/02/2010CA2763008A1 Benzoxazepines as inhibitors of pi3k/mtor and methods of their use and manufacture
12/02/2010CA2762917A1 Salts of methyl (r)-7-[3-amino-4-(2,4,5-trifluoro-phenyl)-butyryl]-3-trifluoromethyl-5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine-1-carboxylate
12/02/2010CA2762137A1 Novel calcium sensing receptor modulating compounds and pharmaceutical use thereof
12/02/2010CA2759182A1 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
12/01/2010EP2256842A1 Organic electroluminescent device
12/01/2010EP2256118A1 Condensed imidazolo derivatives for the inhibition of aromatase
12/01/2010EP2256106A1 3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinases (CDK) and glycogen synthase kinase-3 (GSK-3) modulators
12/01/2010EP2255801A1 Pharmaceutically active isoindoline derivatives
12/01/2010EP2254889A1 Protein kinase inhibitors and use thereof
12/01/2010EP2254887A1 Oxazolidinone derivatives
12/01/2010EP2254864A1 Substituted 4-aminocyclohexane derivatives for the treatment of pain
12/01/2010EP1904494B1 Imidazo[1,2-a]pyridine compounds as vegf-r2 inhibitors
12/01/2010EP1789415B1 Method for producing quaterrylene-3,4:13,14-tetracarboxy diimides by direct synthesis
12/01/2010EP1748986B1 Heterocyclic compounds and their use as aldosterone synthase inhibitors
12/01/2010EP1633750B1 Synthesis of 5-substituted 7-azaindoles and 7-azaindolines
12/01/2010EP1368342B3 Benzimidazole and pyridylimidazole derivatives as ligands for gaba receptors
12/01/2010CN101903388A Spiroindolinone derivatives as anticancer agents
12/01/2010CN101903387A 8-anilin0imidaz0pyridines and their use as anti-cancer and/or anti-inflammatory agents
12/01/2010CN101903386A Dipeptidyl peptidase-IV inhibiting compounds, methods of preparing the same, and pharmaceutical compositions containing the same as active agent
12/01/2010CN101903385A 4-aminopyrimidine derivatives as histamine H4 receptor antagonists
12/01/2010CN101903384A [1h-pyrazolo [3, 4-b] pyridine-4-yl]-phenyle or -pyridin-2-yle derivatives as protein kinase C-theta
12/01/2010CN101903383A Novel compound having affinity for amyloid
12/01/2010CN101903382A Heterocyclic antiviral compounds
12/01/2010CN101903381A Novel compound having affinity for amyloid
12/01/2010CN101903380A 5-aminocyclylmethyl-oxazolidin-2-one derivatives
12/01/2010CN101903343A Compounds for inhibiting KSP kinesin activity
12/01/2010CN101903342A Substituted N-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof as histamine H3 receptor modulators
12/01/2010CN101903339A Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
12/01/2010CN101899047A Beta-amino tetrahydropyrazine, tetrahydropyrimidine and tetrahydropyridine used as dipeptidy peptidase inhibitors for curing or preventing diabetes
12/01/2010CN101899044A Method for synthesizing Gemifloxacin main ring compound
12/01/2010CN101899043A Tylophora ovata base analogs with anti-tumor activity and preparation method and use thereof
12/01/2010CN101899006A 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
12/01/2010CN101250155B Method for preparing chiral alpha-alkenyl(or alkynyl group)-alpha'-alkyl piperidine as well as N-Cbz derivatives and use thereof
11/2010
11/30/2010US7842808 Anti-migraine spirocycles
11/30/2010US7842806 Pyridopyrimidone derivatives, preparation thereof, therapeutic use thereof
11/30/2010US7842712 Indazolinone compositions useful as kinase inhibitors
11/30/2010US7842701 tyrosine kinase inhibitors such as 3-amino-2-(2-chloro-5-hydroxyphenyl)-7-(3-morpholin-4-ylpropoxy)-2,5-dihydro-4H-pyrazolo[4,3-c]quinolin-4-one, used as anticarcinogenic or antiproliferative agents
11/30/2010US7842698 Autoimmune diseases; antiinflamamtory agents, cardiovascular disorders; neurodegenerative diseases, kidney diseases, anticancer agents; platelet aggregation
11/30/2010US7842692 Azaindole derivative having PGD2 receptor antagonistic activity
11/30/2010US7842680 Diene and triene compounds and formulations
11/30/2010CA2583492C Naphthalene and isoquinoline derivatives bearing a pyridyl group for the treatment of skin lesions
11/30/2010CA2541477C Process for preparing 7-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid
11/30/2010CA2456817C Alkyne-aryl-naphthyridin-4 (1h)-one derivatives as type iv phosphodiesterase inhibitor
11/25/2010WO2010135751A2 Fluorescent cellular markers
1 ... 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 ... 646